Adaptimmune Therapeutics shares owned by Palisades Investment Partners
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Palisades Investment Partners
from 13F filings
Historical chart of Palisades Investment Partners investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Palisades Investment Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Palisades Investment Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $25k | 47k | 0.54 |
| 2024-09-30 | $41k | 44k | 0.95 |
More positions owned by Palisades Investment Partners
View all positions for Palisades Investment Partners